]>
IRCT20140622018187N12 IRCT 2020-08-17 Shiraz University of Medical Sciences The effect of Salvia officinalis on lipid profile and quality of life in postmenopausal women Effect of Salvia officinalis Tablet on lipid profile and quality of life in postmenopausal women 2014-05-22 anticipated 102 Complete https://irct.ir/trial/16575 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: The population of eligible women is randomly assigned to two groups using a random permutation block design. The groups are placed and if the numbers 5 to 9 are observed, two people are placed in two groups as BA permutations and we repeat this until we have 51 people in each group. Thus, the samples are divided into two groups A (drug group A) and group B (group consuming drug B) are divided. Women are also informed that they will be accidentally placed in one of the groups, Blinding description: This study is a double-blind study and the patient and the researcher are not aware of receiving sage and placebo, and both are prepared by the Faculty of Pharmacy and will be provided to the patient with a code. After completing the research, the type of intervention will be determined with codes. 2-3 Menopausal and femal climacteric state. Intervention 1: Salvia officinalis extract, 100 mg tablet, three times daily for 8 weeks. Intervention 2: Placebo, tablets 100 mg, three times daily, 8 weeks. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is Because all data has not yet been analyzed and the results from them have not been published
public Sedighe Forouhari
College Of Nursing Midwifery, Shiraz
Shiraz Iran (Islamic Republic of) 71345-1978 +98 71 3647 4257 forouharism@yahoo.com Shiraz University of Medical Sciences scientific Sedighe Forouhari
College Of Nursing Midwifery, Shiraz
Shiraz Iran (Islamic Republic of) 71345-1978 +98 71 3647 4257 foruharis@sums.ac Shiraz University of Medical Sciences Iran (Islamic Republic of) Age between 45 and 60 years Menstruation in the past year Conscious written consent No known physical or mental illness Do not take any hormonal medications to reduce menopausal symptoms in the past month Do not take lipid-lowering drugs BMI below 29 No history of allergy to herbal medicines No smoking, hookah or drug addiction 45 years 60 years Female N95.1 Menopausal and other perimenopausal disorders Treatment - Drugs Placebo Salvia officinalis extract, 100 mg tablet, three times daily for 8 weeks. Placebo, tablets 100 mg, three times daily, 8 weeks. Cholesterol. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Laboratory. Triglycerides. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Laboratory. HDL. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Laboratory. LDL. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Laboratory. Menopause Quality Of Life. Timepoint: 1 week before the intervention and 8 weeks after intervention. Method of measurement: Menopause Quality Of Life Questionnaire. Shiraz University of Medical Sciences Approved 2014-03-19 Ethics Committee, Shiraz University of Medical Sciences Research Deputy, Shiraz University of Medical Science shiraz Shiraz Fars Iran (Islamic Republic of)